115
“If there was a device out there like the Vielight that would have helped me to stay near my peak performance line all the time, it could have been very beneficial.” Dr. Lew Lim emphasized the company’s commitment to science-backed results: “Our mission is to develop evidence- based technologies that promote resilience, focus, and performance. While we are encouraged by these results, we remain committed to rigorous research in collaboration
to make the immense potential of this technology consistent when treating diseases like Parkinson’s. While individual cases inspire hope, the impact of PBM can only be properly measured in the form of published research. One such study found that PBM treatment came with no adverse side effects and was “well tolerated” by participants, supporting “the potential of PBM therapy as a viable home treatment for individuals with dementia.” Vielight is currently undergoing a pivotal clinical trial involving Alzheimer’s patients in Canada and the United States. This involves 228 patients across 12 sites and will be a major milestone in the research of at-home, PBM treatment for this neurodegenerative disease. Accessibility PBM technologies such as Vielight Neuro are designed to be lean, versatile, and easy to use, making them good candidates for aiding our aging population. “Having devices where you have to go to a clinic for treatment doesn’t solve the global problem,” Adams says. “We need devices which are easy to use at home. Everything we develop is battery-powered and rechargeable. You put it on, press a button, and it turns off 20 minutes later. Using it must be that simple.” Professional sports Some NFL and NCAA football players, Olympic athletes, UFC and tennis champions, and their trainers are adopting Vielight Neuro devices, due to their potential to accelerate performance recovery, sharpen
cognitive performance, and enhance mental resilience during demanding training and competition. A University of Utah neurology study with Brigham Young University (BYU) football athletes revealed evidence for Vielight’s photobiomodulation (PBM) technology in high-performance and collision sports. Imaging analyses showed that players using the active Neuro Duo had zero inflammation and improved markers of brain function and performance recovery compared with athletes in the control group. The study indicates that Vielight PBM may enhance cognitive performance, reduce injury markers, and support overall resilience across a competitive season. “I believe this technology has a positive impact on performance, performance recovery and focus at a high level, and I am proud that BYU is among the first to explore this path in collision sports,” said Tom Holmoe, former BYU Athletic Director. Brett Mortensen, Director of BYU Football Athletic Training, explained: “The scientific premise is mitochondrial. The device supports cellular energy (ATP) production and may help with the brain’s adaptive responses during the season. While more research is needed, we have observed encouraging indicators of improved performance recovery and mental sharpness.” Retired NHL goaltender Tim Thomas, a four-time All-Star and Stanley Cup champion, reflected on what this device could have meant for his career:
with leading universities and sports programs.”
Vielight is a biotechnology company dedicated to
harnessing the power of light for therapeutic purposes. Founded by Dr. Lew Lim, Vielight is at the forefront of research and development in the field of photobiomodulation, offering innovative light therapy devices designed to promote healing, enhance cognitive function, and improve overall wellbeing.
To see how Vielight is pioneering the field of photobiomodulation, go to www.vielight.com
Made with FlippingBook Digital Publishing Software